Results 21 to 30 of about 513,529 (353)

Assessment of US Preventive Services Task Force Guideline–Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019

open access: yesJAMA Network Open, 2022
Key Points Question What proportion of screening-eligible women do not have up-to-date US Preventive Services Task Force guideline–concordant cervical cancer screening status, and what are their primary reasons for not receiving timely screening ...
Ryan Suk   +5 more
semanticscholar   +1 more source

Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis

open access: yesmedRxiv, 2021
Background: Cervical cancer screening and prevention programs have been given considerable attention in high-income countries, while only receiving minimal effort in many African countries. This meta-analytic review aimed to estimate the pooled uptake of
N. Yimer   +8 more
semanticscholar   +1 more source

Diagnostic performance of p16/Ki-67 dual immunostaining at different number of positive cells in cervical smears in women referred for colposcopy

open access: yesRadiology and Oncology, 2021
The aim of the study was to evaluate the diagnostic accuracy of p16/Ki-67 dual immunostaining (p16/ Ki-67 DS) in cervical cytology and the number of positive p16/Ki-67 cells to diagnose high grade cervical intraepithelial neoplasia (CIN2+) in colposcopy ...
Gajsek Ursula Salobir   +6 more
doaj   +1 more source

Artificial Intelligence in Cervical Cancer Screening and Diagnosis

open access: yesFrontiers in Oncology, 2022
Cervical cancer remains a leading cause of cancer death in women, seriously threatening their physical and mental health. It is an easily preventable cancer with early screening and diagnosis.
X. Hou   +5 more
semanticscholar   +1 more source

The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry

open access: yesThe Lancet Regional Health. Europe, 2021
Background: The COVID-19 pandemic threatens the impact of cervical cancer screening and global cervical cancer elimination goals. As cervical cancer screening programmes were adjusting to the new situation, we evaluated the intensity, quality, and ...
Urška Ivanuš   +14 more
doaj   +1 more source

A community-based approach to cervical cancer prevention in western Kenya: An AMPATH feasibility project

open access: yesSAGE Open Medicine, 2022
Objectives: Centralized programs have been ineffective in reducing the burden of cervical cancer among Kenyan women. A community-based pilot study was initiated to screen Kenyan women for cervical cancer and to vaccinate their children against human ...
Omenge Orang’o   +8 more
doaj   +1 more source

Robust whole slide image analysis for cervical cancer screening using deep learning

open access: yesNature Communications, 2021
Computer-assisted diagnosis is key for scaling up cervical cancer screening. However, current recognition algorithms perform poorly on whole slide image (WSI) analysis, fail to generalize for diverse staining and imaging, and show sub-optimal clinical ...
Shenghua Cheng   +21 more
semanticscholar   +1 more source

Cervical Cancer Screening Coverage — China, 2018–2019

open access: yesChina CDC Weekly, 2022
What is already known about this topic? The World Health Organization set a 2030 target of 70% cervical cancer screening coverage for women aged 35–45 years. Coverage stood at 37% in China in 2015. What is added by this report?
Mei Zhang   +11 more
semanticscholar   +1 more source

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

open access: yesCa, 2020
The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV testing ...
Elizabeth T. H. Fontham   +17 more
semanticscholar   +1 more source

HPV self-sampling for cervical cancer screening: a systematic review of values and preferences

open access: yesBMJ Global Health, 2021
Introduction The WHO recommends human papillomavirus (HPV) cervical self-sampling as an additional screening method and HPV DNA testing as an effective approach for the early detection of cervical cancer for women aged ≥30 years.
Holly Nishimura   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy